Search

everythinglearnresearchcommunity

for

Search:↓

Hinokiflavone may help treat cancers and other health issues.

Frankincense may help treat COVID-19, but more research is needed.

New wound healing method using nanoparticles in a gel speeds up healing and reduces infection and inflammation.

Anabolic steroid users may face higher risk of severe COVID-19.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

Older age and existing health conditions increase COVID-19 death risk.

Testosterone may both worsen and protect against COVID-19 effects in men.

Silver nanoparticles from Laurus nobilis leaves may be a new, safer antiarthritic treatment.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

Accurate testosterone measurement and standardized lab practices are crucial for diagnosing and managing adult male hypogonadism.

Pharmacists play a crucial role in safe medication use and interdisciplinary collaboration is key to reducing antimicrobial resistance.

Pharmacists play a crucial role in personalized care and medication management.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

Genetic differences affect COVID-19 severity and treatment effectiveness.

Ursolic acid may help develop new anti-inflammatory drugs by affecting immune cells.

Monocytes might be linked to hair loss after COVID-19.

Africa's low COVID-19 rates may be linked to early measures and possibly higher estrogen levels in women.

Common dermatology drugs were considered but are controversial for COVID-19 treatment.

Standardized definitions and better methods are needed to accurately estimate long COVID-19 prevalence.

Long COVID causes lasting symptoms and needs ongoing care.

COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

Canakinumab's effect on COVID-19 outcomes is unclear.

Cepharanthine dry powder inhalers may effectively treat acute lung injury by reducing inflammation.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

HAT-MSCs can effectively engulf harmful microbes and particles, aiding infection treatment.